Jun
22

CVC Capital and Investment Partners Acquire Stake in Alvogen

By

LONDON — The American drug maker Alvogen said on Monday that a consortium of investors led by the European private equity firm CVC Capital Partners had agreed to acquire a controlling stake in the company.

The consortium also includes the Singapore investment firm Temasek Holdings and the New York investment group Vatera Healthcare Partners. The consortium has agreed to acquire the stake in Alvogen from Pamplona Capital Management.

Terms of the transaction were not disclosed. But the deal values Alvogen at about $2 billion, including debt, according to a person familiar with the discussions…

CVC Capital and Investment Partners Acquire Stake in Alvogen

Share
Categories : Uncategorized

Leave a Reply

You must be logged in to post a comment.